Overview
Nilotinib is an inhibitor of the BCR-ABL kinase.
Nilonib
- Generic Name
- Nilotinib Hydrochloride
- Therapeutic Area
- Oncology
- Dosage Form
- Tablets
- Strength
- 150 mg & 200 mg
- Pack Size
- 60’s, 112’s & 120’s
- Registration Number
- 129292 & 129293
Indication
A cancer chemotherapy medication used to treat certain specific types of Chronic Myeloid Leukemia (CML)with a special genetic mutation and other types of CML that have not responded well to other cancer medications.
